Skip to main content

Medicine Matters oncology

Florida Hospital Cancer Institute, USA


Mark A Socinski is the Executive Medical Director of the Florida Hospital Cancer Institute in Orlando, FL. He received his medical degree from the University of Vermont, College of Medicine, and he completed his postdoctoral training including an internship and residency in internal medicine at the Beth Israel Hospital, and medical oncology fellowship at the Dana-Farber Cancer Institute, both at Harvard Medical School.

Dr Socinski has held posts as Director of the Lung Cancer Section at the University of Pittsburgh Medical Center, Clinical Associate Director of the University of Pittsburgh Lung Cancer Specialized Program of Research Excellence (SPORE), Co-Director of UPMC Lung Cancer Center of Excellence, and Co-Leader of the Lung Cancer Program at the University of Pittsburgh Cancer Institute.

He is a member of numerous professional societies, such as the American College of Physicians (ACP), American Society of Clinical Oncology (ASCO), Cancer and Leukemia Group B (Alliance), International Association for the Study of Lung Cancer (IASLC), and American College of Chest Physicians. Dr Socinski is also co-Chair Emeritus of the Thoracic Malignancies Steering Committee for the National Cancer Institute.

Dr Socinski is well-published in peer-reviewed literature, including the New England Journal of Medicine, Journal of Clinical OncologyJournal of Thoracic OncologyCancer, and The Lancet Oncology. His primary research interests cover all aspects of clinical trials related to the thoracic oncology population. He also has been instrumental in the development of many cooperative group and investigator-initiated clinical trials.